# OnCo record nct04950322 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct04950322/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct04950322", "NCT04950322" ;
  schema:name "A Trial of SHR1701 Plus Chemotherapy in Patients With Gastric or Gastroesophageal Cancer"@en ;
  schema:description "A phase 3 trial of Retlirafusp alfa run by Suzhou Suncadia Biopharmaceuticals Co., Ltd., active."@en ;
  schema:url <https://onco.cc/trials/nct04950322/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04950322> ;
  onco:status "active" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "3" ;
  schema:startDate "2021-12-06" ;
  onco:cancers <https://onco.cc/cancers/gastric/> ;
  onco:technologies <https://onco.cc/technologies/bispecific-antibody/>, <https://onco.cc/technologies/checkpoint-inhibitor/> ;
  onco:drugs <https://onco.cc/drugs/retlirafusp-alfa/> ;
  onco:companies <https://onco.cc/companies/hengrui/> .